Efficacy of intra-arterial and intravenous prourokinase in an embolic stroke model evaluated by diffusion-perfusion magnetic resonance imaging

Neurology

Volumn 50, Issue 4, 1998, Pages 870-875

  Takano, K ^a   Carano, R A D ^c   Tatlisumak, T ^a,d   Meiler, M ^c   Sotak, C H ^c   Kleinert, H D ^e   Fisher, M ^a,b,f  

^a Memorial Health Care ^*  (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c Worcester Polytechnic Institute   (United States)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e ABBOTT LABORATORIES   (United States)

^f Memorial Health Care   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; PROUROKINASE; TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN EMBOLISM; BRAIN INFARCTION; CONTROLLED STUDY; DRUG EFFICACY; FIBRINOLYTIC THERAPY; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; REPERFUSION; STROKE;

EID: 0031925103     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.50.4.870     Document Type: Article

References (27)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587.
2. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study. JAMA 1995;274:1017-1025.
3. Hacke W, Zeumer H, Ferbert A, Bruckmann H, del Zoppo GJ. Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebro-basilar occlusive disease. Stroke 1988;19:1216-1222.
4. del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Gent M, Driscoll RM. The Prolyse in acute cerebral thromboembolism trial (PROACT). Stroke 1996;26:164. Abstract.
5. Meden P, Tatlisumak T, Takano K, Carano RAD, Hadley SJ, Fisher M. Thrombolysis with recombinant Desmodus saliva plasminogen activator (rDSPA) in a rat embolic stroke model. Cerebrovasc Dis 1996;6:190. Abstract.
6. Pannell R, Gurewich V. Prourokinase: a study of its stability in plasma and of a mechanism for its selective fibrinolytic effect. Blood 1986;81:853-859.
7. Gurewich V. The sequential, complementary, and synergistic activation of a fibrin-bound plasminogen by tissue plasminogen activator and prourokinase. Fibrinolysis 1989;3:59-66.
8. Bode C, Schoenermark S, Schuler G, Zimmerman R, Schwartz F, Kuebler W. Efficacy of intravenous prourokinase and a combination of prourokinase and urokinase in acute myocardial infarction. Am J Cardiol 1988;61:971-974.
9. Weaver WD, Hartmann JR, Anderson JL, Reddy PS, Sobolski JC, Sasahara AA. New recombinant glycosylated prourokinase for treatment of patients with acute myocardial infarction. J Am Coll Cardiol 1994;24:1242-1248.
10. del Zoppo GJ, Poeck K, Pessin MS, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992;32:78-86.
11. Turner R, LeBihan D. Single-shot diffusion imaging at 2.0 Tesla. J Magn Reson 1990;86:445-452.
12. Basser PJ, Mattiello J, LeBihan D. MR diffusion tensor spectroscopy and imaging. Biophys J 1994;66:259-267.
13. Van Gelderen P, de Vleeshouwer MHM, DesPres D, Pekar J, van Zijl P, Moonen CTW. Water diffusion and acute stroke. Magn Res Med 1994;31:154-163.
14. Formato JE, Hasegawa Y, Sotak CH, Fisher M. Quantitative comparison of diffusion coefficient mapping techniques in ischemic rat brain. Proceedings of the 2nd annual meeting of Society of Magnetic Resonance, 1994.
15. Stejskal EO, Tanner JE. Spin diffusion measurements: spin echoes in the presence of a time-dependent field gradient. J Chem Phys 1965;42:288-292.
16. LeBihan D. Molecular diffusion nuclear magnetic resonance imaging. Magn Reson Q 1991;7:1-30.
17. Carano RAD, Takano K, Meiler MR, et al. Evaluating anti-ischemic effects of a non-selective cation channel blocker, LOE 908 MS, by diffusion and perfusion MRI with postmortem analysis. Proceedings of the 5th annual meeting of International Society of Magnetic Resonance in Medicine, 1997.
18. Hamberg LM, Macfarlane R, Tasdemiroglu E, et al. Measurement of cerebrovascular changes in cats after transient ischemia using dynamic magnetic resonance imaging. Stroke 1993; 24:444-451.
19. Takano K, Latour LL, Formato JE, et al. The role of spreading depression in focal ischemia evaluated by diffusion mapping. Ann Neurol 1996;39:308-318.
20. Minematsu K, Fisher M, Li L, et al. Effects of a novel NMDA antagonist on experimental stroke rapidly and quantitatively assessed by diffusion-weighted MRI. Neurology 1993;42:397-403.
21. Minematsu K, Li L, Sotak CH, Davis MA, Fisher M. Reversible focal ischemic injury demonstrated by diffusion-weighted magnetic resonance imaging. Stroke 1992;23:1304-1310.
22. Overgaard K, Sereghy T, Pedersen H, Boysen G. Effect of delayed with rt-PA in a rat embolic stroke model. J Cereb Blood Flow Metab 1994;14:472-477.
23. Sakurama T, Kitamura R, Kaneko M. Tissue-type plasminogen activator improves neurological functions in a rat model of thromboembolic stroke. Stroke 1994;25:451-456.
24. Lo EH, Pierce AR, Mandeville JB, Rosen BR. Neuroprotection with NBQX in rat focal cerebral ischemia: effects on ADC probability distribution functions and diffusion-perfusion relationships. Stroke 1997;28:439-446.
25. Warach S, Sabounjian LA. Effects of citicoline on the evolution of lesion volume as measured by diffusion-weighted imaging. Stroke 1997;28:233. Abstract.
26. Warach S, Dashe JF, Edelmann RR. Clinical outcome in ischemic stroke predicted by early diffusion-weighted and perfusion magnetic resonance imaging: a preliminary analysis. J Cereb Blood Flow Metab 1996;16:53-59.
27. Hamilton MG, Lee JS, Cummings PJ, Zabramski JM. A comparison of intra-arterial and intravenous tissue-type plasminogen activator on autologous arterial emboli in the cerebral circulation of rabbits. Stroke 1994;25:651-656.